- Previous Close
3.5600 - Open
3.5600 - Bid 3.5300 x --
- Ask 3.5400 x --
- Day's Range
3.5200 - 3.6700 - 52 Week Range
2.9700 - 4.7900 - Volume
20,266,800 - Avg. Volume
11,516,874 - Market Cap (intraday)
9.214B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-3.6600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 8, 2021
- 1y Target Est
--
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig raising, food, supply chain services, agricultural internet, bio-pharmaceutical, and other businesses in China and internationally. The company researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processing activities, as well as raw materials trade. It also provides veterinary pharmaceutical preparations and additives, powders, premixes, injections, oral liquids, solid disinfectants, liquid disinfectants, and other products, as well as creates pig OK management platform, meat sales traceability information system, Internet of Things electronic scale, intelligent breeding equipment, pig OK media, pig customer e-commerce, feed ERP management system, and dealer management platform. Fujian Aonong Biological Technology Group was founded in 2011 and is based in Xiamen, China.
www.aonong.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 603363.SS
View MorePerformance Overview: 603363.SS
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603363.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603363.SS
View MoreValuation Measures
Market Cap
9.27B
Enterprise Value
16.43B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.28
Price/Book (mrq)
--
Enterprise Value/Revenue
1.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
6.61%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
8.76B
Net Income Avi to Common (ttm)
579.35M
Diluted EPS (ttm)
-3.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
382.19M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--